Directness and quality of evidence of bevacizumab combined with chemotherapy for platinum-resistant, recurrent ovarian cancer in the AURELIA trial

 

Authors

  • G.L. Pappagallo Clinical Trial Office, Department of Medical Oncology and Hemato-Oncology, Azienda ULSS 13, Mirano (VE), Italy.
  • M. Rizzo Medical Oncology Unit, A.Cardarelli Hospital, Naples, Italy.

Abstract

No abstract available